Kezar Life Sciences, Inc. (KZR)
NASDAQ: KZR · Real-Time Price · USD
6.76
-0.02 (-0.29%)
At close: Feb 25, 2026, 4:00 PM EST
6.84
+0.08 (1.18%)
After-hours: Feb 25, 2026, 6:20 PM EST
Kezar Life Sciences Market Cap
Kezar Life Sciences has a market cap or net worth of $49.5 million as of February 25, 2026. Its market cap has increased by 10.15% in one year.
Market Cap
49.50M
Enterprise Value
-30.87M
1-Year Change
10.15%
Ranking
Category
Stock Price
$6.76
Market Cap Chart
Since June 21, 2018, Kezar Life Sciences's market cap has decreased from $325.21M to $49.50M, a decrease of -84.78%. That is a compound annual growth rate of -21.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 24, 2026 | 49.65M | 7.79% |
| Dec 31, 2025 | 46.06M | -6.05% |
| Dec 31, 2024 | 49.03M | -28.81% |
| Dec 29, 2023 | 68.87M | -85.69% |
| Dec 30, 2022 | 481.38M | -41.42% |
| Dec 31, 2021 | 821.73M | 240.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 21, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Radiopharm Theranostics | 55.07M |
| NeurAxis | 53.37M |
| MiNK Therapeutics | 53.04M |
| Lipocine | 52.35M |
| Nutriband | 51.66M |
| Estrella Immunopharma | 50.02M |
| Plus Therapeutics | 49.53M |
| Acrivon Therapeutics | 47.33M |